Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001725002-17-000001
Filing Date
2017-12-12
Accepted
2017-12-12 12:32:33
Documents
1
Effectiveness Date
2017-12-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7450
  Complete submission text file 0001725002-17-000001.txt   8523
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 206 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 206 LA JOLLA CA 92037 858-754-3201
Talapo Therapeutics, Inc. (Filer) CIK: 0001725002 (see all company filings)

EIN.: 811677745 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-300507 | Film No.: 171251303